Farnesylation, which is catalyzed by farnesyltransferase, is an important posttranslational process. The function of farnesyltransferase has been previously explored in Cryptococcus neoformans and Candida albicans. Aspergillus fumigatus is an important human opportunistic fungal pathogen in immunocompromised patients. Here we discover the role of the ram1 gene, encoding the β-subunit of farnesyltransferase in A. fumigatus, in the fungal growth and antifungal susceptibility. In this study the ram1 gene was disrupted using A. tumefaciens-mediated transformation. The morphology and radial growth of ram1 were observed. Assays of disk diffusion and broth microdilution were used to determine the susceptibility of ram1 mutant to commonly clinical used antifungals and the farnesyltransferase inhibitor manumycin A. Deletion of ram1 resulted in a reduced radial growth of A. fumigatus but did not affect the microscopic morphology. ram1 showed increased susceptibility to the antifungal amphotericin B; however, its susceptibility to azoles and caspofungin was the same to that to the parental strain. Our data indicate that farnesyltransferase is a potential target for design new antifungal agents.
Introduction
Aspergillus fumigatus is a major opportunistic human pathogen. 1 It is a saprophytic mold which grows naturally on degrading organic materials. Conidia of A. fumigatus can be easily inhaled into the human pulmonary alveoli. [1] [2] [3] In immunocompromised individuals, infection can occur because the conidia cannot be eradicated from the lungs by the compromised immune system. Invasive pulmonary aspergillosis is considered the most severe condition. The incidence of invasive aspergillosis in immunocompromised patients can be as high as 50%. 1, 2 To date, there are only a limited number of antifungal drugs available to treat aspergillosis, including azoles, polyenes, echinocandins, and flucytosine. 4 The number of deaths due to invasive aspergillosis is still very high. Furthermore, drug toxicity and increased antifungal resistance often restrict the use of these antifungals. 5, 6 Therefore, discovering novel and effective antifungal agents is needed to improve the prognosis of invasive aspergillosis. Protein farnesylation, a posttranslational modification which occurs by formation of cysteine thioethers with farnesyl at or near the C-terminus, is important for a number of physiological processes. Farnesyltransferase is a key enzyme involved in catalyzing farnesylation 7, 8 (Fig. 1) . Farnesyltransferase inhibitors, including tipifarnib and lonafarnib, have been used as anticancer drugs in clinical trials. 8 Farnesyltransferases in yeasts and mammals are heterodimeric and consist of α-and β-subunits (Fig. 1) . 7, [9] [10] [11] [12] The α-and β-subunit of farnesyltransferase are encoded by ram2 and ram1, respectively (Fig. 1) . Homologues of farnesyltransferase in human pathogenic fungi were identified. 7, [9] [10] [11] [12] Previous studies indicated that deletion of genes encoding farnesyltransferase subunits results in growth defect in C. glabrata and death of Candida albicans and Cryptococcus neoformans. 9, 11, 12 It has also been demonstrated that inhibiting farnesyltransferase leads to growth reduction of Cn. neoformans. 10 Crystal structures of A. fumigatus farnesyltransferase complexed with substrates and inhibitors reveal it is a potential target for designing antifungal agents. 13 Recently we revealed that farnesyltransferase inhibitors have antifungal activity against Aspergillus and Candida.
14 Therefore, farnesyltransferase may be a new target for the development of antifungal agents. In this study, we further investigate the role of farnesyltransferase in A. fumigatus by deletion ram1 gene, encoding the β-subunit of this enzyme. 5 -ATGCCTGTTATCGCAGCGACTGG-3 screen for ram1 mutant 3 ram1NSR
5 -TTCACCACCAACCATCGCGATAG-3 screen for ram1 mutant
Methods
Fungal and bacterial strains, media, and culture condition
Fungal and bacterial strains and plasmids used in this article are listed in Table 1 . A. fumigatus AF293 was used as wild-type strain for transformation assays. 15 The ram1 gene replacement mutant ( ram1; ram1::A. nidulans pyrG) was constructed by using A. fumigatus AF293.1, a pyrG mutant of AF293. 15 A. fumigatus were grown in minimal medium with glucose at 37
• C unless specified otherwise.
If required, uracil/uridine or hygromycin B were added. For transformation of Escherichia coli, DH10B cells (Invitrogen) were used. E. coli cells were grown at 37
Luria-Bertani (LB) medium supplemented with 50 μg/ml kanamycin or 100 μg/ml ampicillin when required. Strains of Agrobacterium tumefaciens were cultured in LB medium supplemented with or without kanamycin (50 μg/ml) or in induction medium containing 0.2 mM acetosyringone (IMAS). A. fumigatus transformants were selected on IMAS without uracil and uridine but containing 200 μg/ml cefotaxime.
Construction of A. fumigatus ram1 gene disruption mutant
The ram1 gene (AFUA 4G10330) was disrupted in AF293.1 by using A. tumefaciens-mediated transformation according to a method described previously. [16] [17] [18] A 4.1-kb DNA fragment composed of the ram1 gene and its 5 -and 3 -flanking sequences was cloned into the binary plasmid pDHt/sk. The resulting plasmid was named pDHt/ram1. A 200-bp fragment in ram1 was excised from pDHt/ram1 using restriction with PstI and EcoRI. A 1.4-kb A. nidulans pyrG was amplified from pALX223 using a pair of primers. The pyrG (restricted with EcoRI and PstI) was ligated using the EcoRI and PstI-restricted pDHt/ram1 to create the plasmid pDHt/ ram1::pyrG. The binary plasmid pDHt/ ram1::pyrG was transformed into the competent A. tumefaciens strain EHA105 using freeze/thaw method. 19 The A. tumefaciens strain containing pDHt/ ram1::pyrG was designated At-ram1. All of the primers used in this study are listed in Table 2 . In order to disrupt ram1 gene by A. tumefaciensmediated transformation, At-ram1 and AF293.1 were co-cultured. Transformants were selected on minimal media without uracil and uridine. Transformants were consecutively transferred 3 times onto the minimal media agar containing cefotaxime to kill A. tumefaciens. A transformant (referred as ram1) with a homologous ram1 gene replacement was confirmed by Southern hybridization.
The ram1 mutant was reconstituted by integration of the AF293 ram1 allele to create a ram1 + ram1 reconstituted strain ( ram1 c ). ram1 was complemented by transformation with a 6.7-kb DNA fragment composed of the hph gene that confers resistance to hygromycin B (2.6-kb, digested from pAN7-1 with XbaI and SacI) and the wild-type ram1 gene (a 4.1-kb fragment including a 1.2-kb region upstream and 1.0-kb region downstream of the ram1 coding region). The 6.7-kb DNA fragment was transformed into the ram1 by using the A. tumefaciensmediated transformation described above. Transformants were selected on minimal media agar plates supplemented with hygromycin B. Strain with a single inserted copy of the ram1 gene was identified by Southern hybridization with SacI digested genomic DNA according to the instructions from the manufacture (Roche). A 700-bp DNA fragment of ram1 gene was used as probe for the Southern hybridization. The strain was designated as ram1 c .
Antifungal susceptibility testing
The farnesyltransferase inhibitor manumycin A (Enzo Life Science International, Inc., Farmingdale, NY, USA), itraconazole, voriconazole, and amphotericin B were dissolved in 100% dimethyl sulphoxide. Caspofungin was dissolved in sterile water. The broth microdilution assay was done in accordance with the Clinical and Laboratory Standards Institute (CLSI) guidelines for filamentous fungi (CLSI document M38-A2). Stock solutions were prepared in RPMI 1640 (Sigma) plates buffered to a pH of 7.0 with 0.165 M 3-(N-morpholino) propanesulfonic acid (Sigma). The range of final drug concentrations was 16 to 0.03 g/ml for itraconazole, voriconazole, caspofungin and amphotericin B, and 1600 to 3μM for manumycin A. The final inoculum was 0.4 × 10 4 to 5 × 10 4 cfu/ml. The minimal inhibitory concentration (MIC) endpoints for itraconazole, voriconazole, amphotericin B, and manumycin A were designated as the lowest drug concentration with complete growth inhibition at 48 h of incubation at 35
• C. For caspofungin, the minimal effective concentrations against A. fumigatus strains were recorded. E-test was done in accordance with the manufacture's instruction. Candida parapsilosis ATCC 22019 were included in each susceptibility test for quality control and assessment of reproducibility testing. Each assay was performed in triplicate on three different days.
Radial growth assay
Radial growth of AF293, ram1, and ram1 c was performed in triplicate for each strain on Czapek plates. The plates were inoculated centrally with 5 microliters of a conidia suspension containing 1 × 10 3 conidia ml −1 and grown at 28
• C. Radial growth was determined by measuring the colony diameters at day 3, day 5, and day 7.
Results

Disruption and reconstitution of ram1 in A. fumigatus
In order to look for the role of ram1, a ram1 mutant strain was generated by homologous recombination using A. tumefaciens-mediated transformation. Transformants with no detectable polymerase chain reaction (PCR) amplicons with primers designed to amplify the wild-type ram1 locus were selected. Transformant (referred to as ram1) with a homologous ram1 gene replacement confirmed by Southern hybridization was selected and used throughout this study (data not shown). To reconstitute the ram1 strain, a fragment composed of ram1 gene, its promoter and downstream region was transformed into the ram1. Southern blot analysis revealed a single ectopic copy insertion of ram1 gene in the ram1 mutant strain. The reconstituted strain was named ram1 c .
ram1 contributes to radial growth
Deletion of ram1 gene produced a significant reduction in radial growth. Point inoculation of each strain onto EMA and Czapeck plates, followed by incubation at 28
showed that ram1 had profound defects in radial growth compared to AF293 and ram1 c (Fig. 2) . Microscopic examinations of the conidia and mycelia morphology of ram1 revealed no obvious alterations compared to strains AF293 and ram1 c .
ram1 mutant has altered drug susceptibility profiles
The antifungal susceptibility profile of the A. fumigatus ram1 was established by methods of broth microdilution and E-test. ram1 showed a fourfold increased susceptibility to amphotericin B compared to the wild type ( Fig. 3 and Table 3 ). The ram1 mutant also manifested a fourfold increasing sensitivity to manumycin A compared to the wild type. Itraconazole, voriconazole, and caspofungin were found to have similar inhibition profiles against the strains of wild type, ram1, and ram1 c (Fig. 3) .
Discussion
Our previously study demonstrated that farnesyltransferase inhibitors have in vitro antifungal activity against Aspergillus. 14 This leads us to investigate the role of the gene encoding farnesyltransferase in A. fumigatus. The present study reveals that ram1 gene, encoding the β subunit of farnesyltransferase, controls growth, antifungal susceptibility, and virulence in A. fumigatus. The MIC of manumycin A against ram1 is fourfold lower than that against the wild-type A. fumigatus. This indicates that manumycin A is not exclusively targeting on the faresyltransferase in A. fumigatus. This drug may also interact with other sites except for the farnesyltransferase.
Since ram1 is more sensitive to amphotericin B, it appears that farnesylation pathway may play a role in resistance to amphotericin B. The Ras family proteins are a group of monomeric GTPases. 8, [20] [21] [22] Fungal Ras proteins act as molecular switches that transduce signals from the outside of the cell to signaling cascades inside the cell. 20, 22 Farnesylation is required for Ras transforming ability. 8 It has been demonstrated that Ras mutant is hypersensitive to amphotericin B. 23 We postulate that hypersensitivity to amphotericin B of ram1 is caused by the nonfunctioning Ras protein without farnesylation, but specific mechanism of the antifungal hypersensitivity was not investigated further in this study. The susceptibility of ram1 to azoles and caspofungin is same to the wild type. This indicates that disruption of farnesylation pathway does not affect the biosynthesis of ergosterol and beta-glucan. In conclusion, we find that ram1 controls growth and antifungal susceptibility to amphotericin B in A. fumigatus. Our data indicate that farnesyltransferase is a potential target for design new antifungal agents. 
